Clinical trial

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From…

NCT00002704 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00002704
Title Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
Official title TREATMENT OF ISOLATED CNS RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA -- A PEDIATRIC ONCOLOGY GROUP-WIDE PHASE II STUDY
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Leukemia
Intervention type Biological, Drug, Radiation
Interventions filgrastim, asparaginase, cyclophosphamide, daunorubicin hydrochloride, dexamethasone, etoposide, leucovorin calcium, liposomal cytarabine, mercaptopurine, mesna and 6 more
Enrollment 156
Start date Jan 1, 1996
Primary completion Jun 1, 2004
First posted Jul 1, 2004
Last update posted Feb 1, 2013
Countries Canada, Puerto Rico, Switzerland, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies